GLIAPHARM SA has a total of 18 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are C4 THERAPEUTICS INC, VETTORE LLC and NOCION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Singapore | 2 | |
#7 | United States | 2 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Finsterwald Charles | 16 |
#2 | Lengacher Sylvain | 16 |
#3 | Magistretti Pierre | 16 |
#4 | Charles Finsterwald | 1 |
#5 | Pierre Magistretti | 1 |
#6 | Sylvain Lengacher | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020132378A2 | Compositions and methods of treatment for neurological disorders comprising depression | |
CA3083368A1 | Compositions and methods of treatment for neurological disorders comprising a dementia | |
SG11202004971YA | Compositions and methods of treatment for neurological disorders comprising motor neuron diseases |